This deal has aspects of a reverse merger insofar as the impetus for the combination appears to be OMED’s cash balance and Nasdaq listing. The nomianal deal value is $57M, excluding the CVR.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.